Otsuka sees highest patent filings and grants during July in Q3 2023
Otsuka saw the highest growth of 95% in patent filings in August and 104% in grants in July in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 77% and grants by 104%. GlobalData's DataBook provides a comprehensive analysis of Otsuka's patent filings and grants. Buy the databook here.Otsuka has been focused on protecting inventions in Japan(JP) with 61 publications in Q3 2023The Japan(JP) Patent Office dominates the patent filings and grants with nearly 20% filings and 33% grants. The Japan(JP), United States(US), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Otsuka is filings its patents. Among the top granted patent authorities, Otsuka has 33% of its grants in Japan(JP), 17% in United States(US), and 12% in European Patent Office(EPO).Johnson & Johnson could be the strongest competitor for OtsukaJohnson & Johnson and Pfizer secured the top positions according to recent patent publication data.Patents related to rare diseases and health & wellness lead Otsuka's portfolioOtsuka has the highest number of patents in rare diseases followed by, health & wellness and climate change. For rare diseases, nearly 19% of patents were filed and 17% of patents were granted in Q3 2023.Petrochemicals related patents lead Otsuka portfolio followed by automotive materials, and foodOtsuka has highest number of patents in petrochemicals followed by automotive materials, food, cosmetics & toiletries and skincare. For petrochemicals, nearly 2% of patents were filed and 10% of patents were granted in Q3 2023.For comprehensive analysis of Otsuka's filings and grants, buy the databook here.
Access and buy GlobalData’s databook on the latest filings and grants activity for Otsuka here.
What's Your Reaction?
